190 related articles for article (PubMed ID: 31074094)
1. Phenotypic spectrum of ALPK3-related cardiomyopathy.
Al Senaidi K; Joshi N; Al-Nabhani M; Al-Kasbi G; Al Farqani A; Al-Thihli K; Al-Maawali A
Am J Med Genet A; 2019 Jul; 179(7):1235-1240. PubMed ID: 31074094
[TBL] [Abstract][Full Text] [Related]
2. Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
Herkert JC; Verhagen JMA; Yotti R; Haghighi A; Phelan DG; James PA; Brown NJ; Stutterd C; Macciocca I; Leong K; Bulthuis MLC; van Bever Y; van Slegtenhorst MA; Boven LG; Roberts AE; Agarwal R; Seidman J; Lakdawala NK; Fernández-Avilés F; Burke MA; Pierpont ME; Braunlin E; Ḉağlayan AO; Barge-Schaapveld DQCM; Birnie E; van Osch-Gevers L; van Langen IM; Jongbloed JDH; Lockhart PJ; Amor DJ; Seidman CE; van de Laar IMBH
Am Heart J; 2020 Jul; 225():108-119. PubMed ID: 32480058
[TBL] [Abstract][Full Text] [Related]
3. Compound Heterozygosity for Late-Onset Cardiomyopathy-Causative ALPK3 Coding Variant and Novel Intronic Variant Cause Infantile Hypertrophic Cardiomyopathy.
Poleg T; Eskin-Schwartz M; Proskorovski-Ohayon R; Aminov I; Dolgin V; Agam N; Jean M; Safran A; Freund O; Levitas A; Konstantino Y; Birk OS; Westreich R; Haim M
J Cardiovasc Transl Res; 2023 Dec; 16(6):1325-1331. PubMed ID: 37973666
[TBL] [Abstract][Full Text] [Related]
4. Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features.
Jaouadi H; Kraoua L; Chaker L; Atkinson A; Delague V; Levy N; Benkhalifa R; Mrad R; Abdelhak S; Zaffran S
J Hum Genet; 2018 Oct; 63(10):1077-1082. PubMed ID: 30046096
[TBL] [Abstract][Full Text] [Related]
5. Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with
Jorholt J; Formicheva Y; Vershinina T; Kiselev A; Muravyev A; Demchenko E; Fedotov P; Zlotina A; Rygkov A; Vasichkina E; Sejersen T; Kostareva A
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33076350
[TBL] [Abstract][Full Text] [Related]
6. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
[TBL] [Abstract][Full Text] [Related]
7.
Çağlayan AO; Sezer RG; Kaymakçalan H; Ulgen E; Yavuz T; Baranoski JF; Bozaykut A; Harmanci AS; Yalcin Y; Youngblood MW; Yasuno K; Bilgüvar K; Gunel M
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28630369
[TBL] [Abstract][Full Text] [Related]
8. A Pathogenic Variant in
Cheawsamoot C; Phokaew C; Chetruengchai W; Chantranuwat P; Puwanant S; Tongsima S; Khongphatthanayothin A; Shotelersuk V
Circ Genom Precis Med; 2020 Dec; 13(6):e003127. PubMed ID: 33191771
[No Abstract] [Full Text] [Related]
9. [ALPK3 gene-related pediatric cardiomyopathy with craniofacial-skeletal features: a report and literature review].
Ding WW; Wang BZ; Han L; Li ZP; Zhang W; Wang H; Xiao YY
Zhonghua Er Ke Za Zhi; 2021 Sep; 59(9):787-792. PubMed ID: 34645221
[No Abstract] [Full Text] [Related]
10. Mutations in
Salazar-Mendiguchía J; Ochoa JP; Palomino-Doza J; Domínguez F; Díez-López C; Akhtar M; Ramiro-León S; Clemente MM; Pérez-Cejas A; Robledo M; Gómez-Díaz I; Peña-Peña ML; Climent V; Salmerón-Martínez F; Hernández C; García-Granja PE; Mogollón MV; Cárdenas-Reyes I; Cicerchia M; García-Giustiniani D; Lamounier A; Gil-Fournier B; Díaz-Flores F; Salguero R; Santomé L; Syrris P; Olivé M; García-Pavía P; Ortiz-Genga M; Elliott PM; Monserrat L;
Heart; 2020 Sep; 106(17):1342-1348. PubMed ID: 32451364
[TBL] [Abstract][Full Text] [Related]
11. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
[TBL] [Abstract][Full Text] [Related]
12. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
Lopes LR; Garcia-Hernández S; Lorenzini M; Futema M; Chumakova O; Zateyshchikov D; Isidoro-Garcia M; Villacorta E; Escobar-Lopez L; Garcia-Pavia P; Bilbao R; Dobarro D; Sandin-Fuentes M; Catalli C; Gener Querol B; Mezcua A; Garcia Pinilla J; Bloch Rasmussen T; Ferreira-Aguar A; Revilla-Martí P; Basurte Elorz MT; Bautista Paves A; Ramon Gimeno J; Figueroa AV; Franco-Gutierrez R; Fuentes-Cañamero ME; Martinez Moreno M; Ortiz-Genga M; Piqueras-Flores J; Analia Ramos K; Rudzitis A; Ruiz-Guerrero L; Stein R; Triguero-Bocharán M; de la Higuera L; Ochoa JP; Abu-Bonsrah D; Kwok CYT; Smith JB; Porrello ER; Akhtar MM; Jager J; Ashworth M; Syrris P; Elliott DA; Monserrat L; Elliott PM
Eur Heart J; 2021 Aug; 42(32):3063-3073. PubMed ID: 34263907
[TBL] [Abstract][Full Text] [Related]
13. Contiguous Gene Deletion of Chromosome 15q25.2q25.3 in Biallelic
Grutters LA; Klein Wassink-Ruiter JS; Dijkhuizen T; Nijenhuis HP; Jongbloed JDH; Herkert JC
Circ Genom Precis Med; 2023 Oct; 16(5):493-495. PubMed ID: 37671554
[No Abstract] [Full Text] [Related]
14. Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy.
Almomani R; Verhagen JM; Herkert JC; Brosens E; van Spaendonck-Zwarts KY; Asimaki A; van der Zwaag PA; Frohn-Mulder IM; Bertoli-Avella AM; Boven LG; van Slegtenhorst MA; van der Smagt JJ; van IJcken WF; Timmer B; van Stuijvenberg M; Verdijk RM; Saffitz JE; du Plessis FA; Michels M; Hofstra RM; Sinke RJ; van Tintelen JP; Wessels MW; Jongbloed JD; van de Laar IM
J Am Coll Cardiol; 2016 Feb; 67(5):515-25. PubMed ID: 26846950
[TBL] [Abstract][Full Text] [Related]
15. Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy.
Puckelwartz MJ; Pesce LL; Dellefave-Castillo LM; Wheeler MT; Pottinger TD; Robinson AC; Kearns SD; Gacita AM; Schoppen ZJ; Pan W; Kim G; Wilcox JE; Anderson AS; Ashley EA; Day SM; Cappola T; Dorn GW; McNally EM
J Am Heart Assoc; 2021 Apr; 10(7):e019944. PubMed ID: 33764162
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy.
Ader F; Jedraszak G; Janin A; Billon C; Buisson NR; Bloch A; Bensalah M; De Sandre-Giovannoli A; Goudal A; Marsili L; Cazeneuve C; Charron P; Millat G; Richard P;
Clin Genet; 2024 Jun; 105(6):676-682. PubMed ID: 38356193
[TBL] [Abstract][Full Text] [Related]
17. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy.
Matsumoto Y; Hayashi T; Inagaki N; Takahashi M; Hiroi S; Nakamura T; Arimura T; Nakamura K; Ashizawa N; Yasunami M; Ohe T; Yano K; Kimura A
J Muscle Res Cell Motil; 2005; 26(6-8):367-74. PubMed ID: 16465475
[TBL] [Abstract][Full Text] [Related]
19. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
[TBL] [Abstract][Full Text] [Related]
20. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
